# Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma

> **NCT00586846** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 40 (actual)

## Conditions studied

- Osteosarcoma

## Interventions

- **DRUG:** Cisplatin
- **DRUG:** Doxorubicin
- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT00586846
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00586846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00586846, "Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00586846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*